Hernán Carranza

Updated Frequency of EGFR and KRAS Mutations in NonSmall-Cell Lung Cancer in Latin America: The Latin-American Consortium for the Investigation of Lung Cancer (CLICaP)

Óscar Arrieta, Andrés F. Cardona, Claudio Martín et al. · Journal of Thoracic Oncology · 2015 · 195 citations · Full text

Medicine, Genetics, Oncology +11

The impact of common and rare EGFR mutations in response to EGFR tyrosine kinase inhibitors and platinum-based chemotherapy in patients with non-small cell lung cancer

Óscar Arrieta, Andrés F. Cardona, Luis Corrales et al. · Lung Cancer · 2014 · 84 citations

Medicine, Oncology, Pharmacology +17

Immunotherapy at any line of treatment improves survival in patients with advanced metastatic non‐small cell lung cancer (NSCLC) compared with chemotherapy (Quijote‐CLICaP)

Alejandro Ruíz-Patiño, Óscar Arrieta, Andrés F. Cardona et al. · Thoracic Cancer · 2019 · 62 citations · Full text

Medicine, Immunology, Oncology +16

EGFR exon 20 insertion in lung adenocarcinomas among Hispanics (geno1.2-CLICaP)

Andrés F. Cardona, Leonardo Rojas, Zyanya Lucía Zatarain-Barrón et al. · Lung Cancer · 2018 · 60 citations

Medicine, Genetics, Molecular Genetics +12

Efficacy and safety of Levetiracetam vs. other antiepileptic drugs in Hispanic patients with glioblastoma

Andrés F. Cardona, Leonardo Rojas, Beatriz Wills et al. · Journal of Neuro-Oncology · 2017 · 44 citations

Medicine, Neurology, Pharmacology +12